Portillo’s Inc. Announces Third Quarter 2025 Financial Results
Globenewswire· 2025-11-04 13:00
OAK BROOK, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the one-of-a-kind restaurant concept known for its menu of Chicago-style favorites, today reported financial results for the third quarter ended September 28, 2025. Third Quarter 2025 Performance Highlights (vs. Third Quarter 2024): Total revenue of $181.4 million, an increase of 1.8% or $3.2 millionSame-restaurant sales decrease of -0.8%Operating income of $5.4 million, a decrease of $10.6 mil ...
Apium Joins Red Cat Futures Initiative to Advance Swarming Autonomy for Tactical Drones
Globenewswire· 2025-11-04 13:00
Partnership follows successful U.S. Army testing of Apium’s Swarm Autopilot and Ground Control system integrated into Red Cat’s Teal Drone Operational CapabilitiesSAN JUAN, Puerto Rico, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Apium Swarm Robotics, Inc. a developer of distributed autonomy for unmanned systems, has signed a Memorandum of Agreement (MOA) with Red Cat Holdings, Inc. (Nasdaq: RCAT), a U.S. based provider of advanced all-domain drone and robotic solutions for defense and national security. Through this ...
Northern Technologies International Corporation Secures Multi-Year Offshore Oil & Gas Production Asset Preservation Contract in Brazil
Globenewswire· 2025-11-04 13:00
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today announced that its 85%-owned subsidiary, Zerust Prevenção de Corrosão S.A. (Zerust Brazil), has secured a three-year contract for a major offshore project with a leading global engineering, procurement, and construction (EPC) company to provide advanced corrosion ...
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
Globenewswire· 2025-11-04 13:00
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net Revenue grew 49% in Q3 2025, as compared to Q3 2024, continuing momentum with the launch of the Vial Access Needle (VAN) and enhanced incentive program with key distributorsAPONVIE® Net Revenue grew 173% in Q3 2025, as compared to Q3 2024, supported by increased adoption and momentum building wi ...
Huntington Bancshares Preferreds Update: Rating Changes
Seeking Alpha· 2025-11-04 13:00
With a focus on REITs, ETFs, Preferreds, and 'Dividend Champions' across asset classes, members gain complete access to our research and our suite of trackers and portfolios targeting premium dividend yields up to 10%.iREIT®+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income, diversification, and inflation hedging. Get started with a Free Two-Week Trial and take a look at ou ...
Terrestrial Energy Inc. Appoints Sarfraz M. Taj as Vice President of Business Development
Globenewswire· 2025-11-04 13:00
Nuclear industry veteran brings two decades of M&A, strategic development, and international business experience from Constellation Energy Latest strategic hire reinforces Terrestrial Energy's commitment to attracting top-tier talent as company accelerates Integral Molten Salt Reactor (IMSR) commercialization following public listing CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or the “Company”), a developer of small modular nuclear plants u ...
Trio Petroleum Corp. (TPET) Announces Strategic Acquisition of Cash Flow positive production in Alberta
Globenewswire· 2025-11-04 13:00
Malibu, California, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: TPET) (“Trio” or the “Company”), a California oil and gas company, today is pleased to announce that its wholly owned Canadian Subsidiary Trio Petroleum Canada, Corp. (the 'Company') has acquired a high-value mineral lease covering a quarter section located at NW 7-50-1W4 in Alberta, Canada. This strategic purchase strengthens the company’s production base and underscores its ongoing commitment to expanding shareholder ...
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
Globenewswire· 2025-11-04 13:00
PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in the following upcoming investor conferences in November and December: Guggenheim’s 2nd Annual Healthcare Innovation Conference: Webcasted fireside chat at 10:30 a.m. ET on Tuesday, November 11, 20 ...
Forte Minerals Closes a Second C$5.7 Million Strategic Investment and Additional Participation from Existing Strategic Investor
Globenewswire· 2025-11-04 13:00
“Not for distribution to United States newswire services or for dissemination in the United States.” VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA) is pleased to announce the closing of its previously announced non-brokered private placement (the “Offering”) with a second strategic investor for aggregate gross proceeds of C$5.7 million. Under the Offering, the Company issued 6,333,333 common shares at ...
Dianthus Therapeutics to Participate in Four Investor Conferences During November
Globenewswire· 2025-11-04 13:00
NEW YORK and WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the company’s participation in four upcoming investor conferences. Marino Garcia, CEO of Dianthus Therapeutics, will participate in fireside chats and host one-on-one investor meetings at the following conferences: Guggenheim 2nd Annual Healt ...